Literature DB >> 16970213

Population-based prevalence of repeated group A beta-hemolytic streptococcal pharyngitis episodes.

Jennifer L St Sauver1, Amy L Weaver, Laura J Orvidas, Robert M Jacobson, Steven J Jacobsen.   

Abstract

OBJECTIVE: To define the population-based 3-year period prevalence of repeated group A beta-hemolytic streptococcal (GABHS) pharyngitis episodes in children between 4 and 15 years of age. PATIENTS AND METHODS: Residents of Rochester, Minn (age, 4-15 years), who had 3 or more GABHS pharyngitis episodes In 1 year, at least 1 month apart, between January 1, 1996, and December 31, 1998, were Identified using the resources of the Rochester Epidemiology Project (N=536). Pharyngitis episodes (evidence of a sore throat with or without presence of fever) followed by either a positive rapid streptococcus test result or a positive plate culture test result were considered positive GABHS episodes. Age- and sex-specific prevalence rates were calculated, assuming that all residents 4 to 15 years of age in Rochester during 1996 to 1998 were at risk.
RESULTS: A total of 208 children met our definition for repeated GABHS episodes between 1996 and 1998 and were included in this study. Approximately 1% of children between the ages of 4 and 15 years experienced repeated GABHS pharyngitis episodes between 1996 and 1998. This estimate increased to approximately 2% among children 4 to 6 years of age and decreased to 0.1% among children 13 to 15 years old.
CONCLUSION: A relatively small proportion (1%) of children between 4 and 15 years of age experienced repeated GABHS episodes in a 3-year period; however, this proportion represents a substantial number of children who are affected at the population level. Given the increased costs associated with treating repeated GABHS episodes, further studies are necessary to determine how best to reduce episodes and treatment costs in this age group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16970213     DOI: 10.4065/81.9.1172

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

1.  Evaluation of Simplexa Group A Strep Direct Kit Compared to Hologic Group A Streptococcal Direct Assay for Detection of Group A Streptococcus in Throat Swabs.

Authors:  Deirdre L Church; Tracie Lloyd; Oscar Larios; Daniel B Gregson
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

Review 2.  Antibiotics for preventing recurrent sore throat.

Authors:  Gareth J Y Ng; Stephanie Tan; Anh N Vu; Chris B Del Mar; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2015-07-14

3.  Streptococcus pyogenes evades adaptive immunity through specific IgG glycan hydrolysis.

Authors:  Andreas Naegeli; Eleni Bratanis; Christofer Karlsson; Oonagh Shannon; Raja Kalluru; Adam Linder; Johan Malmström; Mattias Collin
Journal:  J Exp Med       Date:  2019-05-15       Impact factor: 14.307

Review 4.  Bacterial Lymphatic Metastasis in Infection and Immunity.

Authors:  Matthew K Siggins; Shiranee Sriskandan
Journal:  Cells       Date:  2021-12-23       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.